A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test

Hannah P. Yang, David K. Walmer, Delson Merisier, Julia C. Gage, Laura Bell, Sameera Rangwala, Niwashin Shrestha, Lori Kobayashi, Paul S. Eder, Philip E. Castle

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The analytic performance of a low-cost, research-stage DNA test for the most carcinogenic human papillomavirus (HPV) genotypes (HPV16, HPV18, and HPV45) in aggregate was evaluated among carcinogenic HPV-positive women, which might be used to decide who needs immediate colposcopy in low-resource settings (" triage test"). We found that HPV16/18/45 test agreed well with two DNA tests, a GP5+/6+ genotyping assay (Kappa = 0.77) and a quantitative PCR assay (at a cutpoint of 5000 viral copies) (Kappa = 0.87). DNA sequencing on a subset of 16 HPV16/18/45 positive and 16 HPV16/18/45 negative verified the analytic specificity of the research test. It is concluded that the HPV16/18/45 assay is a promising triage test with a minimum detection of approximately 5000 viral copies, the clinically relevant threshold.

Original languageEnglish (US)
Pages (from-to)112-114
Number of pages3
JournalJournal of Virological Methods
Volume176
Issue number1-2
DOIs
StatePublished - Sep 2011
Externally publishedYes

Fingerprint

Human papillomavirus 18
Human papillomavirus 16
Triage
Costs and Cost Analysis
Colposcopy
DNA
DNA Sequence Analysis
Research
Genotype
Polymerase Chain Reaction

Keywords

  • Cervical cancer
  • HPV genotypes
  • HPV test
  • Human papillomavirus (HPV)

ASJC Scopus subject areas

  • Virology

Cite this

A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test. / Yang, Hannah P.; Walmer, David K.; Merisier, Delson; Gage, Julia C.; Bell, Laura; Rangwala, Sameera; Shrestha, Niwashin; Kobayashi, Lori; Eder, Paul S.; Castle, Philip E.

In: Journal of Virological Methods, Vol. 176, No. 1-2, 09.2011, p. 112-114.

Research output: Contribution to journalArticle

Yang, HP, Walmer, DK, Merisier, D, Gage, JC, Bell, L, Rangwala, S, Shrestha, N, Kobayashi, L, Eder, PS & Castle, PE 2011, 'A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test', Journal of Virological Methods, vol. 176, no. 1-2, pp. 112-114. https://doi.org/10.1016/j.jviromet.2011.05.024
Yang, Hannah P. ; Walmer, David K. ; Merisier, Delson ; Gage, Julia C. ; Bell, Laura ; Rangwala, Sameera ; Shrestha, Niwashin ; Kobayashi, Lori ; Eder, Paul S. ; Castle, Philip E. / A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test. In: Journal of Virological Methods. 2011 ; Vol. 176, No. 1-2. pp. 112-114.
@article{dc8a97115fd541a6952bd090f3ca60eb,
title = "A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test",
abstract = "The analytic performance of a low-cost, research-stage DNA test for the most carcinogenic human papillomavirus (HPV) genotypes (HPV16, HPV18, and HPV45) in aggregate was evaluated among carcinogenic HPV-positive women, which might be used to decide who needs immediate colposcopy in low-resource settings ({"} triage test{"}). We found that HPV16/18/45 test agreed well with two DNA tests, a GP5+/6+ genotyping assay (Kappa = 0.77) and a quantitative PCR assay (at a cutpoint of 5000 viral copies) (Kappa = 0.87). DNA sequencing on a subset of 16 HPV16/18/45 positive and 16 HPV16/18/45 negative verified the analytic specificity of the research test. It is concluded that the HPV16/18/45 assay is a promising triage test with a minimum detection of approximately 5000 viral copies, the clinically relevant threshold.",
keywords = "Cervical cancer, HPV genotypes, HPV test, Human papillomavirus (HPV)",
author = "Yang, {Hannah P.} and Walmer, {David K.} and Delson Merisier and Gage, {Julia C.} and Laura Bell and Sameera Rangwala and Niwashin Shrestha and Lori Kobayashi and Eder, {Paul S.} and Castle, {Philip E.}",
year = "2011",
month = "9",
doi = "10.1016/j.jviromet.2011.05.024",
language = "English (US)",
volume = "176",
pages = "112--114",
journal = "Journal of Virological Methods",
issn = "0166-0934",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test

AU - Yang, Hannah P.

AU - Walmer, David K.

AU - Merisier, Delson

AU - Gage, Julia C.

AU - Bell, Laura

AU - Rangwala, Sameera

AU - Shrestha, Niwashin

AU - Kobayashi, Lori

AU - Eder, Paul S.

AU - Castle, Philip E.

PY - 2011/9

Y1 - 2011/9

N2 - The analytic performance of a low-cost, research-stage DNA test for the most carcinogenic human papillomavirus (HPV) genotypes (HPV16, HPV18, and HPV45) in aggregate was evaluated among carcinogenic HPV-positive women, which might be used to decide who needs immediate colposcopy in low-resource settings (" triage test"). We found that HPV16/18/45 test agreed well with two DNA tests, a GP5+/6+ genotyping assay (Kappa = 0.77) and a quantitative PCR assay (at a cutpoint of 5000 viral copies) (Kappa = 0.87). DNA sequencing on a subset of 16 HPV16/18/45 positive and 16 HPV16/18/45 negative verified the analytic specificity of the research test. It is concluded that the HPV16/18/45 assay is a promising triage test with a minimum detection of approximately 5000 viral copies, the clinically relevant threshold.

AB - The analytic performance of a low-cost, research-stage DNA test for the most carcinogenic human papillomavirus (HPV) genotypes (HPV16, HPV18, and HPV45) in aggregate was evaluated among carcinogenic HPV-positive women, which might be used to decide who needs immediate colposcopy in low-resource settings (" triage test"). We found that HPV16/18/45 test agreed well with two DNA tests, a GP5+/6+ genotyping assay (Kappa = 0.77) and a quantitative PCR assay (at a cutpoint of 5000 viral copies) (Kappa = 0.87). DNA sequencing on a subset of 16 HPV16/18/45 positive and 16 HPV16/18/45 negative verified the analytic specificity of the research test. It is concluded that the HPV16/18/45 assay is a promising triage test with a minimum detection of approximately 5000 viral copies, the clinically relevant threshold.

KW - Cervical cancer

KW - HPV genotypes

KW - HPV test

KW - Human papillomavirus (HPV)

UR - http://www.scopus.com/inward/record.url?scp=79960601632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960601632&partnerID=8YFLogxK

U2 - 10.1016/j.jviromet.2011.05.024

DO - 10.1016/j.jviromet.2011.05.024

M3 - Article

VL - 176

SP - 112

EP - 114

JO - Journal of Virological Methods

JF - Journal of Virological Methods

SN - 0166-0934

IS - 1-2

ER -